0001213900-23-048683.txt : 20230613
0001213900-23-048683.hdr.sgml : 20230613
20230613205421
ACCESSION NUMBER: 0001213900-23-048683
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230613
FILED AS OF DATE: 20230613
DATE AS OF CHANGE: 20230613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahal Jeetinder Singh
CENTRAL INDEX KEY: 0001882877
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39138
FILM NUMBER: 231012785
MAIL ADDRESS:
STREET 1: C/O JASPER THERAPEUTICS, INC.
STREET 2: 2200 BRIDGE PARKWAY, SUITE 102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jasper Therapeutics, Inc.
CENTRAL INDEX KEY: 0001788028
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 842984849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 6505491400
MAIL ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp
DATE OF NAME CHANGE: 20190912
4
1
ownership.xml
X0407
4
2023-06-13
0
0001788028
Jasper Therapeutics, Inc.
JSPR
0001882877
Mahal Jeetinder Singh
C/O JASPER THERAPEUTICS, INC.
2200 BRIDGE PARKWAY, SUITE 102
REDWOOD CITY
CA
94065
0
1
0
0
See Remarks
1
Voting Common Stock
2023-06-13
4
M
0
9000
0.71
A
296223
D
Voting Common Stock
2023-06-13
4
S
0
9000
1.6572
D
287223
D
Stock Option (right to buy)
0.71
2023-06-13
4
M
0
9000
0.00
A
2030-05-31
Voting Common Stock
9000
173713
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.69, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares have vested and shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Chief Operating Officer, Chief Financial Officer and Corporate Secretary
/s/ Jeet Mahal
2023-06-13